Sitala Bio Ltd. has divulged complement factor B (CFB) inhibitors reported to be useful for the treatment of age-related macular degeneration, schizophrenia, atypical hemolytic uremic syndrome, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback